Marshall Wace North America’s Calix CALX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$9.28M Sell
187,663
-23,918
-11% -$1.1M 0.04% 371
2021
Q2
$10.1M Buy
211,581
+11,441
+6% +$502K 0.04% 376
2021
Q1
$6.94M Sell
200,140
-47,087
-19% -$1.74M 0.03% 480
2020
Q4
$7.36M Buy
+247,227
New +$6.1M 0.03% 449
2019
Q4
Sell
-35,436
Closed -$226K 1312
2019
Q3
$226K Buy
+35,436
New +$223K ﹤0.01% 944
2018
Q3
Sell
-21,881
Closed -$171K 958
2018
Q2
$171K Buy
+21,881
New +$154K ﹤0.01% 1291

Other funds holding CALX

Marshall Wace North America's CALX Position: Q3 2021 in Review

Marshall Wace North America reduced its Calix (CALX) stake by 11% in Q3 2021, selling an estimated $1.1M and leaving 187,663 shares worth $9.28M. The position accounts for 0.04% of the portfolio, ranked #371.

Marshall Wace North America first reported a position in CALX in Q2 2018 and has held it in 6 quarters since. The position peaked at $10.1M in Q2 2021. 191 funds tracked by Wall St. Rank hold CALX as of Q3 2021.

  • Marshall Wace North America held 187,663 shares of Calix worth $9.28M as of Q3 2021.
  • Marshall Wace North America sold 23,918 Calix shares in Q3 2021, an estimated $1.1M.
  • Calix made up 0.04% of Marshall Wace North America's portfolio in Q3 2021, its #371 holding.
  • Marshall Wace North America first reported a position in Calix in Q2 2018 and has held it in 6 quarters since.
  • Marshall Wace North America's Calix position peaked at $10.1M in Q2 2021.
  • 191 funds tracked by Wall St. Rank held Calix as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.